Das Suchergebnis hat sich seit Ihrer Suchanfrage verändert. Eventuell werden Dokumente in anderer Reihenfolge angezeigt.
  • Treffer 1 von 2
Zurück zur Trefferliste

COVID‐19 and implications for dermatological and allergological diseases

Zitieren Sie bitte immer diese URN: urn:nbn:de:bvb:20-opus-217860
  • COVID‐19, caused by the coronavirus SARS‐CoV‐2, has become pandemic. A further level of complexity opens up as soon as we look at diseases whose pathogenesis and therapy involve different immunological signaling pathways, which are potentially affected by COVID‐19. Medical treatments must often be reassessed and questioned in connection with this infection. This article summarizes the current knowledge of COVID‐19 in the light of major dermatological and allergological diseases. It identifies medical areas lacking sufficient data and drawsCOVID‐19, caused by the coronavirus SARS‐CoV‐2, has become pandemic. A further level of complexity opens up as soon as we look at diseases whose pathogenesis and therapy involve different immunological signaling pathways, which are potentially affected by COVID‐19. Medical treatments must often be reassessed and questioned in connection with this infection. This article summarizes the current knowledge of COVID‐19 in the light of major dermatological and allergological diseases. It identifies medical areas lacking sufficient data and draws conclusions for the management of our patients during the pandemic. We focus on common chronic inflammatory skin diseases with complex immunological pathogenesis: psoriasis, eczema including atopic dermatitis, type I allergies, autoimmune blistering and inflammatory connective tissue diseases, vasculitis, and skin cancers. Since several other inflammatory skin diseases display related or comparable immunological reactions, clustering of the various inflammatory dermatoses into different disease patterns may help with therapeutic decisions. Thus, following these patterns of skin inflammation, our review may supply treatment recommendations and thoughtful considerations for disease management even beyond the most frequent diseases discussed here.zeige mehrzeige weniger

Volltext Dateien herunterladen

Metadaten exportieren

Weitere Dienste

Teilen auf Twitter Suche bei Google Scholar Statistik - Anzahl der Zugriffe auf das Dokument
Metadaten
Autor(en): Timo Buhl, Stefan Beissert, Evelyn Gaffal, Matthias Goebeler, Michael Hertl, Cornelia Mauch, Kristian Reich, Enno Schmidt, Michael P. Schön, Michael Sticherling, Cord Sunderkötter, Claudia Traidl‐Hoffmann, Thomas Werfel, Dagmar Wilsman‐Theis, Margitta Worm
URN:urn:nbn:de:bvb:20-opus-217860
Dokumentart:Artikel / Aufsatz in einer Zeitschrift
Institute der Universität:Medizinische Fakultät / Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie
Sprache der Veröffentlichung:Englisch
Titel des übergeordneten Werkes / der Zeitschrift (Englisch):JDDG: Journal der Deutschen Dermatologischen Gesellschaft
Erscheinungsjahr:2020
Band / Jahrgang:18
Heft / Ausgabe:8
Erste Seite:815
Letzte Seite:824
Originalveröffentlichung / Quelle:JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2020, 18(8):815-824. DOI: 10.1111/ddg.14195
DOI:https://doi.org/10.1111/ddg.14195
Allgemeine fachliche Zuordnung (DDC-Klassifikation):6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Freie Schlagwort(e):COVID-19; allergies; dermatology
Datum der Freischaltung:20.07.2021
Lizenz (Deutsch):License LogoCC BY-NC: Creative-Commons-Lizenz: Namensnennung, Nicht kommerziell 4.0 International